Obtain critical regulatory updates and gain access to China & North Asia’s market

IBC Asia’s Pharmaceutical Regulatory Summit Asia aims to deliver and clarify the latest regulatory updates in a complex Asian regulatory landscape. In addition, pharmaceutical safety and market access strategies will be discussed for efficient access to the China and North Asian pharmaceutical market.

This is the ONLY event which focuses on North Asian pharmaceutical regulations that offers both industry and authoritative professionals to provide critical regulatory updates and to share advice and experiences in the Asian market.

What’s New for 2014?

• Biosimilars, OTC, Orphan drugs, fixed-dose combination products (FDC) and Vaccines regulations
• Pharmaceutical marketing regulations
• Quality by design
• Pediatric Investigational Plans (PIPs)
• More industry case studies focusing on dossier submissions
• E-regulatory affairs